Cargando…
Ranolazine: Multifaceted Role beyond Coronary Artery Disease, a Recent Perspective
Ranolazine is a piperazine derivative approved as an antianginal. Primarily used as a second-line antianginal in stable coronary artery disease. Ranolazine blocks the late Na + current and prevents the rise of cytosolic calcium. It decreases myocardial wall tension and improves coronary blood flow....
Autores principales: | Ghosh, Gopal Chandra, Ghosh, Raktim Kumar, Bandyopadhyay, Dhrubajyoti, Chatterjee, Krishnarpan, Aneja, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448470/ https://www.ncbi.nlm.nih.gov/pubmed/31007857 http://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_18_18 |
Ejemplares similares
-
Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018) -
Disseminated neurocysticercosis presenting as affective mood disorder with chronic tension type headache
por: Chatterjee, Krishnarpan, et al.
Publicado: (2013) -
An intriguing relation between atrial fibrillation and contrast-induced nephropathy
por: Ashish, Kumar, et al.
Publicado: (2018) -
Safety and Efficacy of Extremely Low LDL-Cholesterol Levels and Its Prospects in Hyperlipidemia Management
por: Bandyopadhyay, Dhrubajyoti, et al.
Publicado: (2018) -
The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
por: Calcagno, Simone, et al.
Publicado: (2020)